Showing results (211-220 of 549) with videos related to

Sort By:
Pageof 55
Oncology|May 1, 1994
Goserelin in premenopausal advanced breast cancer: clinical and endocrine evaluation of responsive patientsE Bajetta, N Zilembo, R Buzzoni, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1987
The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levelsP Lissoni, A Bastone, R Sala, et al.
British Journal of Cancer|July 1, 1994
Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancerE Bajetta, N Zilembo, R Buzzoni, et al.
British Journal of Cancer|April 7, 1998
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implicationsS Viviani, E Camerini, V Bonfante, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's diseaseL Devizzi, L Maffioli, V Bonfante, et al.
Cancer|April 1, 1997
Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck: results of a phase II multicenter studyV Gebbia, G Mantovani, A Farris, et al.
Oncology|January 1, 1995
Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapyM di Bartolomeo, E Bajetta, F de Braud, et al.
Journal of Thoracic Disease|January 21, 2012
Long-term follow up of patients affected by pulmonary carcinoid at the Istituto Nazionale Tumori of Milan: a retrospective analysisS Pusceddu, L Catena, M Valente, et al.
British Journal of Cancer|October 1, 1995
Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitorN Zilembo, C Noberasco, E Bajetta, et al.
American Journal of Clinical Oncology|June 1, 1995
Epirubicin plus medroxyprogesterone as second-line treatment of advanced prostatic cancer. A study by the Italian Trials in Medical Oncology GroupA Di Leo, E Bajetta, R Buzzoni, et al.
Pageof 55